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The article outlines improved methodological approaches to preclinical screening of antihypoxic and cytoprotective drugs. 
To investigate the effect of Mexidol, carbamylated darbepoetin, darbepoetin, and placebo (isotonic solution for the substance) 
against the background of hypoxic and cytotoxic effects on cell culture. Get data on the cytoprotective and antihypoxic 
therapeutic corridor of Mexidol. A placebo-controlled screening test of mexidol, darbepoetin, and carbamylated darbepoetin 
was conducted on pig leukocytes cultures. Hanks solution was used as the nutrient medium. From the preparations, working 
solutions of a certain concentration were prepared; for Mexidol, 150 μg/ml; the remaining substances, 500 ng/ml. Data on the 
cytoprotective and antihypoxic therapeutic corridor of mexidol were obtained. In this experience, there are no significant 
differences between darbepoetin and its derivative from placebo. The technique used in the experiment, has shown its 
effectiveness and the possibility of its further use as a screening system. Derivatives of erythropoietin at 60-minute incubation 
do not have either antihypoxic or cytoprotective effects on leukocytes of pigs. Mexidol has antihypoxic effect at a 





Currently, there are many ways to determine cell 
viability, which have high sensitivity, throughput and 
specificity. They range from the most routine analysis 
of the exclusion of trypan-blue dyes to a very complex 
analysis of individual cells, for example, using 
RAMAN microscopy. Cell viability is often defined as 
the number of healthy cells in a sample. Methods for 
assessing cell viability can be divided into those that 
analyze entire populations and those that include 
analysis of individual cells. Of course, the analysis of 
the whole population is quick, however, it gives a less 
detailed result than measurements of viability at the 
level of individual cells [1]. One of the first methods of 
evaluation Cell viability was a test for the exclusion of 
dye trypan blue, which is still widely used. It is based 
on the fact that viable cells have an intact cell 
membrane that does not pass the dye and thus excludes 
staining. Dead and damaged cells absorb the trypan 
blue color and, as a result, turn blue, because their 
membrane is no longer able to control the passage of 
macromolecules. There are techniques in which dyes 
are washed out of damaged cells with buffer solutions 
and in this case, viable cells remain stained [2, 3, 4]. 
Pathological processes at the cellular level, as well 
as adaptation processes, can be thought of as non-
specific, one-by-one reactions that result in the 
formation of a non-specific response. The basis of the 
pathogenesis of cytotoxic and hypoxic damage to cells 
and tissues is always oxidative stress, which is a 
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cascade of reactions that activate free-radical 
processes. 
Oxidative or oxidative stress is a consequence of an 
imbalance in the functioning of the pro- and 
antioxidant systems of the cell, which in turn leads to 
damage to cellular structures and individual 
macromolecules (proteins, lipids, DNA), cell 
membrane damage and, consequently, cell death [5,6]. 
Disruption of the structure and functions of 
mitochondria leads to a decrease in the level of ATP in 
the cell and the cessation of the functioning of ion 
pumps, which in turn leads to an imbalance of 
potassium, sodium and calcium ions inside the cell and 
the extracellular space. All this leads to the activation 
of the complex of enzyme systems - phospholipase, 
proteinkinase [7]. Damage to the cytoskeleton, cell 
membrane and changes in the intracellular 
concentration of ions leads to the formation of acidosis, 
as a result of the accumulation of metabolic products 
such as lactate and others. Adaptive cell reserves 
initially activate metabolism. However, as soon as the 
damaging factor damages the mitochondria, the 
metabolism becomes disorganized, the damage 
becomes critical, and the cell dies [8]. 
Currently, it has been proven that free radical cell 
damage is one of the main factors in the pathogenesis 
of over 100 human diseases, including ischemic 
disorders of the brain and cardiac circulation, acute 
fetal hypoxia, diabetes mellitus [9]. 
In the experiment, the effect of a number of 
substances was evaluated: darbepoetin, carbamylated 
darbepoetin and mexidol (ethylmethylhydroxypyridine 
succinate). 
Mexidol (ethylmethylhydroxypyridine succinate), 
as stated in the official instructions to the drug, is an 
inhibitor of free-radical processes, membrane protector, 
has antihypoxic, stressprotective, nootropic, 
anticonvulsant and anxiolytic action. The mechanism 
of action of mexidol is due to its antioxidant, 
antihypoxic and membrane-protective action. It inhibits 
lipid peroxidation, increases the activity of superoxide 
dismutase, increases the lipid-protein ratio, reduces the 
viscosity of the membrane, increases its fluidity. By 
changing the activity of calcium-membransvyazannyh 
enzyme phosphodiesterase, adenylate cyclase, 
acetylcholinesterase) receptor complexes 
(benzodiazepine, GABA, acetylcholine), mexidol 
enhances their ability to bind to ligands, and 
contributes to maintaining the structural and functional 
organization of biological membranes, transport of 
neurotransmitters and improve synaptic transmission. 
Mexidol increases the content of dopamine in the brain. 
It causes activation of aerobic glycolysis and a decrease 
in the degree of inhibition of oxidative processes in the 
Krebs cycle under hypoxic conditions with an increase 
in ATP and creatinephosphate, activation of the 
energy-synthesizing functions of mitochondria, and 
stabilization of cell membranes. The drug improves 
metabolism and blood supply to the brain, improves 
microcirculation and rheological properties of blood, 
reduces platelet aggregation. Stabilizes membrane 
structures of blood cells (erythrocytes and platelets) 
during hemolysis. It has a hypolipidemic effect, 
reduces the content of total cholesterol and LDL. 
Erythropoietins are cytokines that are produced in 
the human body, and this product is a genetically 
determined process. Synthesis of erythropoietin is one 
of the responses to a decrease in the oxygen content in 
cells. Hypoxia leads to the production of hypoxia-
induced factor-1 (HIF-1), followed by the production 
of mRNA and, in fact, erythropoietin [11, 12]. 
Darbepoetin (DPO) is a genetically modified 
erythropoietin that has all the properties of its ancestor. 
Due to its improved structure, DPO has a large 
molecular weight (37.1 kDa, not 30.4 kDa) and due to 
which there is an increase in its half-life and, 
consequently, the frequency of use of the drug 
decreases [1, 13]. Also known form of darbepoetin, 
which contains carbamylated group - carbamylated 
darbepoetin (KDPO). KDPO does not affect 
hematopoiesis, but has all the same cytoprotective 
properties, and also has a longer half-life, which makes 
it promising as a drug for the treatment of hypoxic 
disorders [13]. 
It is worth noting the insufficient amount of 
information in the modern literature on the 
cytoprotective and antihypoxic properties of 
darbepoetin and carbamylated darbepoetin, as well as a 
small amount of preclinical studies of these substances, 




To investigate the effect of Mexidol, carbamylated 
darbepoetin, darbepoetin, and placebo (isotonic 
solution for the substance) against the background of 
hypoxic and cytotoxic effects on cell culture. Get data 
on the cytoprotective and antihypoxic therapeutic 




The study was performed on a culture of neutrophil 
cells isolated from fresh blood of the pig. Neutrophils 
were isolated by collecting 30 ml of blood in tubes 
with EDTA (2.7% 1:10), followed by four times 
centrifugation (1000 rpm for 5 min) and dilution of the 
cell sediment in 5, and then 30 ml of phosphate-
buffered saline solution. Then the cells were counted in 
the Goryaev chamber and the cell number was adjusted 
to 2 million / ml with the nutrient medium. 100 μl of 
cell suspension was introduced into each hole of a 96-
well plate and incubation was performed for 1 hour at 
37° C. 
Hanks solution was used as the nutrient medium. In 
the experiment, the effect of Mexidol, carbamylated 
darbepoetin, darbepoetin, and placebo (isotonic 
solution for the substance) against the background of 
hypoxic and cytotoxic effects on cell culture was 
studied. From the preparations, working solutions of a 
certain concentration were prepared; for Mexidol, 150 
μg / ml; the remaining substances, 500 ng/ml. In every 
two adjacent holes 1-10 of a 96-well plate, a certain 
amount of Hanks solution was added, respectively, 
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100, 90, 88, 61 and 129 μl, and 132 μl of the drug were 
added to the 11th and 12th holes of the tablet, and no 
Hanks solution was added thus creating a concentration 
gradient from zero to theoretically toxic. Then, the 
solution was transferred sequentially from 2 
consecutive holes to the previous two, so that 100 μl of 
solution remained in each hole. With this method of 
introducing liquids, the volumes in all the holes were 
the same, and the exact concentrations in the rows of 
the holes are presented in Table.1. 
Concentrations were selected on the basis of their 
therapeutic concentrations indicated in the instructions 
for preparations, taking into account interspecific 
recalculation and pharmacokinetic data [14]. As a 
simulation of hypoxia, oils in a volume of 50 μl were 
injected into the A-D series of a standard 96-well plate, 
and a formalin solution of 5 μl 0.4% was added to 
create a cytotoxic effect. The cells were fixed with 96% 
alcohol, and 1% crystal violet, 100 μl each, was used as 
a dye. 
 
Table 1. The concentration of the tested substances in the rows of holes on the tablet 
Number of row holes in 
the tablet 
1 and 2 3 and 4 5 and 6 7 and 8 9 and 10 11 and 12 
Mexidol 0 0.298137 ng/μl 2.98137 ng/μl 14.9069 ng/ μl 29.8137 ng/μl 150 ng/μl 
SDPO, DPO, placebo 0 0.00099 ng/μl 0.009938 ng/μl 0.04969 ng/μl 0.09938 ng/μl 0.5 ng/μl 
 
After removing the dye, phosphate-buffered saline 
was washed three times [15]. The calculation of the 
optical density characterizing the survival of cells was 
carried out at 650/492 nm on Multiskan FC of the 
company ThermoFisher Scientific Inc., Finland. 
Descriptive statistics were applied to all data: the data 
was checked for normal distribution. The type of 
distribution was determined by the criterion of Shapiro-
Wilk. In the case of a normal distribution, the mean 
and standard error of the mean were calculated. In 
cases of abnormal distribution, the median and quartile 
range were calculated. Intergroup differences were 
analyzed by parametric (Student's t-test) or non-
parametric (Mann-Whitney test) methods, depending 
on the type of distribution [16]. Statistical analysis was 
performed using Statistica 10.0 software. 
 
Results and Discussion 
 
Analysis of the optical coefficient characterizing the 
average number of cells in 1 and 2 wells of the plate 
(control, without drugs) with photometry with a 
wavelength of 620 nm in comparison with photometry 
with a wavelength of 492 nm showed that the 
dispersion is higher when using a wavelength of 620 
nm. Analysis of the dynamics of the number of cells in 
1 and 2 wells of the plate with photometry of 620 nm 
showed that when exposed to hypoxia, cell survival 
was 0.2932 ± 0.145, with cytotoxic effects of formalin 
- 0.3336 ± 0.124. Photometry 492 nm, when exposed to 
hypoxia - 0.1155 ± 0.0363, cytotoxic damage - 0.1244 
± 0.0362. Considering this stability, we decided to use 
only photometry data obtained at 492 nm in the 
analysis. The results are presented in tables 2 and 3. As 
can be seen from table 2, only Mexidol at a 
concentration of 15 ng/μl has a slight antihypoxic 
effect. Mexidol also has a cytoprotective effect at a 
concentration of 3 ng/ml (Table 3). With a decrease 
and increase in concentrations of Mexidol does not 
cause a significantly significant therapeutic effect. This 
makes it possible to predict a therapeutic corridor in the 
range of indicated concentrations. Carbamylated 
darbepoetin and darbepoetin do not cause significant 
antihypoxic effects when compared with placebo. 
However, the average values of tables 2 and 3 can be 
traced to a parabolic curve, the peak of which is in the 
middle of the concentration gradient. 
 
Table 2. The results of photometry of the painted environment of neutrophil blood of pigs after hypoxic exposure for 1 
hour 







































































* -p <0.05 when compared with the Placebo group. 
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Table 3. The results of photometry of the painted environment of neutrophil blood of pigs after cytotoxic exposure for 1 
hour with formalin solution 







































































* -p <0.05 when compared with the Placebo group 
 
This fact confirms the correctness of the selected 
and recalculated concentrations, the extreme values of 
which do not have pharmacological efficacy. In this 
experiment, no significant differences in carbamylated 
darbepoetin and darbepoetin from placebo were found, 
which may have several explanations. According to 
previously published papers [11], not all cells have 
receptors for poets and their derivatives, and poets have 
an antihypoxic effect through secondary mediators in a 
living organism over time. It is possible that the hour 
incubation in our experiment was not enough. In 
addition, we do not exclude the controversial and so far 




1. The technique used in the experiment, has shown 
its effectiveness and the possibility of its further use as 
a screening system. 
2. Derivatives of erythropoietin at 60-minute 
incubation do not have either antihypoxic or 
cytoprotective effects on leukocytes of pigs. 
3. Mexidol has an antihypoxic effect at a 
concentration of 15 ng/μl and cytoprotective - at a 
concentration of 3 ng/μl. 
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